Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research

N. Silvestris, G. Ciliberto, P. De Paoli, G. Apolone, M. L. Lavitrano, M. A. Pierotti, G. Stanta, On the behalf of the "dynamic medicine OECI group"

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The increasing use of genomics to define the pattern of actionable mutations and to test and validate new therapies for individual cancer patients, and the growing application of liquid biopsy to dynamically track tumor evolution and to adapt molecularly targeted therapy according to the emergence of tumor clonal variants is shaping modern medical oncology., In order to better describe this new therapeutic paradigm we propose the term "Liquid dynamic medicine" in the place of "Personalized or Precision medicine". Clinical validation of the "Liquid dynamic medicine" approach is best captured by N-of-1 trials where each patient acts as tester and control of truly personalized therapies.
Original languageEnglish
Pages (from-to)128
JournalJournal of Experimental and Clinical Cancer Research
Volume36
Issue number1
DOIs
Publication statusPublished - Sep 13 2017

Fingerprint

Medicine
Clinical Trials
Precision Medicine
Research
Neoplasms
Medical Oncology
Therapeutics
Genomics
Biopsy
Mutation

Keywords

  • Clinical trials
  • Dynamic
  • Fluid
  • N-of-1 trials
  • Personalized medicine
  • Target therapy

Cite this

Silvestris, N., Ciliberto, G., Paoli, P. D., Apolone, G., Lavitrano, M. L., Pierotti, M. A., ... group", O. T. B. O. T. . M. OECI. (2017). Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research. Journal of Experimental and Clinical Cancer Research, 36(1), 128. https://doi.org/10.1186/s13046-017-0598-x [doi]

Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research. / Silvestris, N.; Ciliberto, G.; Paoli, P. De; Apolone, G.; Lavitrano, M. L.; Pierotti, M. A.; Stanta, G.; group", On the behalf of the "dynamic medicine OECI.

In: Journal of Experimental and Clinical Cancer Research, Vol. 36, No. 1, 13.09.2017, p. 128.

Research output: Contribution to journalArticle

Silvestris, N. ; Ciliberto, G. ; Paoli, P. De ; Apolone, G. ; Lavitrano, M. L. ; Pierotti, M. A. ; Stanta, G. ; group", On the behalf of the "dynamic medicine OECI. / Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research. In: Journal of Experimental and Clinical Cancer Research. 2017 ; Vol. 36, No. 1. pp. 128.
@article{47fe2d584a5e4a27bb2610c3af88343c,
title = "Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research",
abstract = "The increasing use of genomics to define the pattern of actionable mutations and to test and validate new therapies for individual cancer patients, and the growing application of liquid biopsy to dynamically track tumor evolution and to adapt molecularly targeted therapy according to the emergence of tumor clonal variants is shaping modern medical oncology., In order to better describe this new therapeutic paradigm we propose the term {"}Liquid dynamic medicine{"} in the place of {"}Personalized or Precision medicine{"}. Clinical validation of the {"}Liquid dynamic medicine{"} approach is best captured by N-of-1 trials where each patient acts as tester and control of truly personalized therapies.",
keywords = "Clinical trials, Dynamic, Fluid, N-of-1 trials, Personalized medicine, Target therapy",
author = "N. Silvestris and G. Ciliberto and Paoli, {P. De} and G. Apolone and Lavitrano, {M. L.} and Pierotti, {M. A.} and G. Stanta and group{"}, {On the behalf of the {"}dynamic medicine OECI}",
note = "LR: 20170919; JID: 8308647; OTO: NOTNLM; 2017/08/11 [received]; 2017/09/07 [accepted]; epublish",
year = "2017",
month = "9",
day = "13",
doi = "10.1186/s13046-017-0598-x [doi]",
language = "English",
volume = "36",
pages = "128",
journal = "Journal of Experimental and Clinical Cancer Research",
issn = "0392-9078",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research

AU - Silvestris, N.

AU - Ciliberto, G.

AU - Paoli, P. De

AU - Apolone, G.

AU - Lavitrano, M. L.

AU - Pierotti, M. A.

AU - Stanta, G.

AU - group", On the behalf of the "dynamic medicine OECI

N1 - LR: 20170919; JID: 8308647; OTO: NOTNLM; 2017/08/11 [received]; 2017/09/07 [accepted]; epublish

PY - 2017/9/13

Y1 - 2017/9/13

N2 - The increasing use of genomics to define the pattern of actionable mutations and to test and validate new therapies for individual cancer patients, and the growing application of liquid biopsy to dynamically track tumor evolution and to adapt molecularly targeted therapy according to the emergence of tumor clonal variants is shaping modern medical oncology., In order to better describe this new therapeutic paradigm we propose the term "Liquid dynamic medicine" in the place of "Personalized or Precision medicine". Clinical validation of the "Liquid dynamic medicine" approach is best captured by N-of-1 trials where each patient acts as tester and control of truly personalized therapies.

AB - The increasing use of genomics to define the pattern of actionable mutations and to test and validate new therapies for individual cancer patients, and the growing application of liquid biopsy to dynamically track tumor evolution and to adapt molecularly targeted therapy according to the emergence of tumor clonal variants is shaping modern medical oncology., In order to better describe this new therapeutic paradigm we propose the term "Liquid dynamic medicine" in the place of "Personalized or Precision medicine". Clinical validation of the "Liquid dynamic medicine" approach is best captured by N-of-1 trials where each patient acts as tester and control of truly personalized therapies.

KW - Clinical trials

KW - Dynamic

KW - Fluid

KW - N-of-1 trials

KW - Personalized medicine

KW - Target therapy

U2 - 10.1186/s13046-017-0598-x [doi]

DO - 10.1186/s13046-017-0598-x [doi]

M3 - Article

VL - 36

SP - 128

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

SN - 0392-9078

IS - 1

ER -